UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis

Intensive Care Medicine, 2016-04, Vol.42 (4), p.505-520

2016

Volltextzugriff (PDF)

Management Practices for Asparaginase-associated Coagulopathy: A Survey of Pediatric Oncologists

Journal of pediatric hematology/oncology, 2022-11, Vol.44 (8), p.e1023-e1028

2022

Volltextzugriff (PDF)

Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis

Thrombosis research, 2018-11, Vol.171, p.1-6

2018

Volltextzugriff (PDF)

Antithrombin III improved neutrophil extracellular traps in lung after the onset of endotoxemia

The Journal of surgical research, 2017-02, Vol.208, p.140-150

2017

Volltextzugriff (PDF)

Role of direct oral anticoagulants in the treatment of cancer‐associated venous thromboembolism: guidance from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2018-09, Vol.16 (9), p.1891-1894

2018

Volltextzugriff (PDF)

High dose antithrombin supplementation in early preeclampsia: A randomized, double blind, placebo-controlled study

Thrombosis research, 2016-04, Vol.140, p.7-13

2016

Volltextzugriff (PDF)

Antithrombin Attenuates Vascular Leakage via Inhibiting Neutrophil Activation in Acute Lung Injury

Critical care medicine, 2013-12, Vol.41 (12), p.e439-e446

2013

Volltextzugriff (PDF)

Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2015-11, Vol.13 (11), p.2119-2126

2015

Volltextzugriff (PDF)

Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease

Cochrane database of systematic reviews, 2017-11, Vol.11 (11), p.CD011373

2017

Volltextzugriff (PDF)

Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial

JAMA : the journal of the American Medical Association, 2015-04, Vol.313 (13), p.1336

2015

Volltextzugriff (PDF)

Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO

Critical care (London, England), 2020-01, Vol.24 (1), p.19-19, Article 19

2020

Volltextzugriff (PDF)

The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial

Blood, 2021-12, Vol.138 (22), p.2173-2184

2021

Volltextzugriff (PDF)

Heparin-Induced Thrombocytopenia: A Comprehensive Clinical Review

Journal of the American College of Cardiology, 2016-05, Vol.67 (21), p.2519-2532

2016

Volltextzugriff (PDF)

Risk of bleeding with dabigatran in atrial fibrillation

JAMA internal medicine, 2015-01, Vol.175 (1), p.18

2015

Volltextzugriff (PDF)

Bivalirudin Started during Emergency Transport for Primary PCI

The New England journal of medicine, 2013-12, Vol.369 (23), p.2207-2217

2013

Volltextzugriff (PDF)

Clinical review: molecular mechanisms underlying the role of antithrombin in sepsis

Critical care (London, England), 2006-01, Vol.10 (1), p.209-209

Wiedermann, Christian J

2006

Volltextzugriff (PDF)

Antithrombin: anti-inflammatory properties and clinical applications

Thrombosis and haemostasis, 2016-04, Vol.115 (4), p.712-728

2016

Volltextzugriff (PDF)

Management of Bleeding With Non–Vitamin K Antagonist Oral Anticoagulants in the Era of Specific Reversal Agents

Circulation (New York, N.Y.), 2016-07, Vol.134 (3), p.248-261

2016

Volltextzugriff (PDF)

Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation

JAMA internal medicine, 2016-11, Vol.176 (11), p.1662

2016

Volltextzugriff (PDF)

Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin

Critical care medicine, 2021-07, Vol.49 (7), p.1129-1136

2021

Volltextzugriff (PDF)

Treatment of bleeding complications in patients on anticoagulant therapy

Blood, 2019-01, Vol.133 (5), p.425-435

2019

Volltextzugriff (PDF)

Reversal of anticoagulants: an overview of current developments

Thrombosis and haemostasis, 2015-09, Vol.113 (5), p.931-942

2015

Volltextzugriff (PDF)

BRIGHT-4 trial: bivalirudin strikes back

The Lancet (British edition), 2023-04, Vol.401 (10383), p.1157-1158

2023

Volltextzugriff (PDF)

Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation

Chest, 2016-12, Vol.150 (6), p.1302-1312

2016

Volltextzugriff (PDF)

Direct oral anticoagulants in patients with VTE and cancer: a systematic review and meta-analysis

Chest, 2015-02, Vol.147 (2), p.475-483

2015

Volltextzugriff (PDF)

1 – 25 von 3.862

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.378)
Mit Volltextzugriff
(2.468)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(3.561)
Science & Technology
(2.841)
Life Sciences & Biomedicine
(2.794)
Antithrombins - Therapeutic Use
(1.811)
Male
(1.706)
Female
(1.612)
Anticoagulants - Therapeutic Use
(1.289)
Cardiovascular System & Cardiology
(1.124)
Middle Aged
(1.074)
Aged
(978)
Biological And Medical Sciences
(919)
Medical Sciences
(912)
Heparin - Therapeutic Use
(835)
Adult
(826)
Hematology
(794)
Cardiac & Cardiovascular Systems
(622)
Peripheral Vascular Disease
(612)
Animals
(569)
Treatment Outcome
(541)
Recombinant Proteins - Therapeutic Use
(540)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(3.855)
Ovid SocietyJournals and Single Titles
(1.866)
IngentaConnect
(1.680)
EZB Electronic Journals Library
(1.381)
IngentaConnect Journals
(831)
ScienceDirect
(775)
Publisher or Other Site
(771)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(496)
Wiley-Blackwell Journals
(466)
Wiley Online Library
(385)
SpringerLink
(317)
Thieme - Connect here FIRST to enable access
(267)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(203)
SAGE Publications
(143)
Oxford Journals
(121)
Taylor & Francis Journals
(117)
Oxford Journals 2020 Medicine
(108)
Taylor & Francis Online
(100)
Taylor & Francis Online
(84)
BMJ journals (British Medical Journal and others)
(58)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis

Management Practices for Asparaginase-associated Coagulopathy: A Survey of Pediatric Oncologists

Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis

Antithrombin III improved neutrophil extracellular traps in lung after the onset of endotoxemia

Role of direct oral anticoagulants in the treatment of cancer‐associated venous thromboembolism: guidance from the SSC of the ISTH

High dose antithrombin supplementation in early preeclampsia: A randomized, double blind, placebo-controlled study

Antithrombin Attenuates Vascular Leakage via Inhibiting Neutrophil Activation in Acute Lung Injury

Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH

Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease

Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial

Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO

The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial

Heparin-Induced Thrombocytopenia: A Comprehensive Clinical Review

Risk of bleeding with dabigatran in atrial fibrillation

Bivalirudin Started during Emergency Transport for Primary PCI

Clinical review: molecular mechanisms underlying the role of antithrombin in sepsis

Antithrombin: anti-inflammatory properties and clinical applications

Management of Bleeding With Non–Vitamin K Antagonist Oral Anticoagulants in the Era of Specific Reversal Agents

Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation

Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin

Treatment of bleeding complications in patients on anticoagulant therapy

Reversal of anticoagulants: an overview of current developments

BRIGHT-4 trial: bivalirudin strikes back

Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation

Direct oral anticoagulants in patients with VTE and cancer: a systematic review and meta-analysis

Suchergebnisse filtern